Indaptus Therapeutics INDP
NASDAQ INDP
$2.85 -0.44 (-13.37%)
At close: Sep 29, 2026 · 4:00 PM EDT

Indaptus Therapeutics (INDP) EV to CFO (2021)

Updated

Indaptus Therapeutics' (INDP) EV to CFO stood at 6.42 in Q2 2021, down 73.2% from the prior quarter.

Analysis

Indaptus Therapeutics (INDP) EV to CFO (2021) Analysis & Trends

On a TTM basis, Indaptus Therapeutics' EV to CFO came in at -12.22 as of Jun 30, 2021.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Indaptus Therapeutics 210.93 Mn 183.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 6.42
Mar 31, 2021 23.93
API Access

Indaptus Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=INDP&period=max&api_key=YOUR_API_KEY